Aspen sees Mounjaro Africa sales above $124 million in 2027

Aspen Pharmacare sees weight-loss drugs driving earnings

South African drugmaker Aspen Pharmacare said the rollout of its weight-loss drugs will help drive a 17% rise in earnings next year. Aspen sells Mounjaro, the weight-loss drug made by US manufacturer Eli Lilly, in South Africa. It will begin offering its own generic drug, targeting local markets as well as South America and the Middle East, according to Reuters.Demand from Africa currently accounts for only a fraction of the global weight-loss d…

Mounjaro leads South Africa’s $187 million weight-loss drug boom as Aspen prepares Ozempic rival

South Africa’s market for popular diabetes and weight-management medicines has grown to almost $187 million (R3 billion), with Mounjaro leading sales as Aspen Pharmacare prepares a generic alternative to medicines such as Ozempic.

Aspen sees Mounjaro Africa sales above $124 million in 2027

By Nqobile Dludla JOHANNESBURG, Sept 3 (Reuters) - Aspen Pharmacare expects African sales of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in its ​current financial year, buoyed by surging demand...